Teva Pharmaceutical Industries Limited
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2011
Total Assets: $50.14B
Liabilities Breakdown FY2011
Total Liabilities: $27.80B
Asset Breakdown
Total Assets: $50.14B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.10B | 2.2% |
| Accounts Receivable | $6.21B | 12.4% |
| Inventory | $5.01B | 10.0% |
| Property, Plant & Equipment | $5.95B | 11.9% |
| Goodwill | $18.29B | 36.5% |
| Intangible Assets | $10.32B | 20.6% |
| Other Assets | $3.27B | 6.5% |
Liabilities Breakdown
Total Liabilities: $27.80B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $11.39B | 41.0% |
| Other Liabilities | $16.41B | 59.0% |